A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer.
(Q39580436)
scientific article published on 25 July 2012
scientific article published on 25 July 2012
Language:
other details
| description | scientific article published on 25 July 2012 |
External Links
| (P356) |
10.1007/S10637-012-9857-Z
|
| (P698) |
22828917
|